D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 53 Citations 10,881 96 World Ranking 11519 National Ranking 419

Overview

What is he best known for?

The fields of study he is best known for:

  • Enzyme
  • Cancer
  • Biochemistry

Philippe G. Frank focuses on Cell biology, Caveolae, Internal medicine, Endocrinology and Reverse Warburg effect. The concepts of his Cell biology study are interwoven with issues in Cell, Endocytosis, Albumin and Ligand. His Caveolae research integrates issues from Transcytosis, Caveolin 1, In vivo and Blood vessel.

In his work, Tumor progression and Metabolism is strongly intertwined with Cancer research, which is a subfield of Internal medicine. His work carried out in the field of Endocrinology brings together such families of science as CD36 and Atheroma. While the research belongs to areas of Reverse Warburg effect, Philippe G. Frank spends his time largely on the problem of Stromal cell, intersecting his research to questions surrounding Cancer-Associated Fibroblasts.

His most cited work include:

  • The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma (798 citations)
  • Caveolin-1-deficient Mice Are Lean, Resistant to Diet-induced Obesity, and Show Hypertriglyceridemia with Adipocyte Abnormalities (467 citations)
  • Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism (393 citations)

What are the main themes of his work throughout his whole career to date?

Cell biology, Caveolae, Caveolin 1, Cholesterol and Internal medicine are his primary areas of study. His studies examine the connections between Cell biology and genetics, as well as such issues in Cell, with regards to Cell growth. Many of his research projects under Caveolae are closely connected to Cellular differentiation with Cellular differentiation, tying the diverse disciplines of science together.

His Caveolin 1 study combines topics in areas such as Apoptosis, Sphingolipid, Signal transduction and Homeostasis. His work in Cholesterol addresses subjects such as Efflux, which are connected to disciplines such as Phospholipid efflux. His Internal medicine research includes themes of Endocrinology, Oncology and Cancer research.

He most often published in these fields:

  • Cell biology (39.00%)
  • Caveolae (36.00%)
  • Caveolin 1 (37.00%)

What were the highlights of his more recent work (between 2012-2021)?

  • Cancer research (23.00%)
  • Cancer (14.00%)
  • Cholesterol (25.00%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Cancer research, Cancer, Cholesterol, Breast cancer and Caveolin 1. The Cancer research study combines topics in areas such as Cell migration, Cancer cell, Scavenger receptor, Signal transduction and Docetaxel. His Cancer research is included under the broader classification of Internal medicine.

Cholesterol is the subject of his research, which falls under Biochemistry. His research integrates issues of Inflammation and Caveolae, Caveolin in his study of Caveolin 1. Philippe G. Frank has researched Caveolae in several fields, including Transcytosis, Endothelium and Lipoprotein.

Between 2012 and 2021, his most popular works were:

  • Scavenger receptor class B type I regulates cellular cholesterol metabolism and cell signaling associated with breast cancer development (82 citations)
  • SR-BI: Linking Cholesterol and Lipoprotein Metabolism with Breast and Prostate Cancer. (41 citations)
  • Endothelial caveolin-1 plays a major role in the development of atherosclerosis (37 citations)

In his most recent research, the most cited papers focused on:

  • Enzyme
  • Cancer
  • Biochemistry

Philippe G. Frank mostly deals with Cancer research, Signal transduction, Cancer cell, Cell biology and Scavenger receptor. The study incorporates disciplines such as MAPK/ERK pathway, Biochemistry, Foam cell, RHOA and Metastasis Suppressor Gene in addition to Cancer research. He combines subjects such as Lipid metabolism, Internal medicine, Reverse cholesterol transport and Phosphodiesterase with his study of Signal transduction.

His studies in Cancer cell integrate themes in fields like Cell migration, Extracellular, Metastasis, Intracellular and Breast cancer. In general Cell biology study, his work on Caveolin 1 and Caveolae often relates to the realm of Vascular endothelial growth factor B, thereby connecting several areas of interest. His Scavenger receptor study integrates concerns from other disciplines, such as Cancer, Cell signaling, Protein kinase B, Protein kinase A and PI3K/AKT/mTOR pathway.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma

Stephanos Pavlides;Diana Whitaker-Menezes;Remedios Castello-Cros;Neal Flomenberg.
Cell Cycle (2009)

1233 Citations

Caveolin-1-deficient Mice Are Lean, Resistant to Diet-induced Obesity, and Show Hypertriglyceridemia with Adipocyte Abnormalities

Babak Razani;Terry P. Combs;Xiao Bo Wang;Philippe G. Frank.
Journal of Biological Chemistry (2002)

676 Citations

Ketones and lactate "fuel" tumor growth and metastasis: Evidence that epithelial cancer cells use oxidative mitochondrial metabolism

Gloria Bonuccelli;Aristotelis Tsirigos;Diana Whitaker-Menezes;Stephanos Pavlides.
Cell Cycle (2010)

606 Citations

Microvascular hyperpermeability in caveolin-1 (-/-) knock-out mice. Treatment with a specific nitric-oxide synthase inhibitor, L-NAME, restores normal microvascular permeability in Cav-1 null mice.

William Schubert;Philippe G. Frank;Scott E. Woodman;Hideyuki Hyogo.
Journal of Biological Chemistry (2002)

438 Citations

Caveolin, Caveolae, and Endothelial Cell Function

Philippe G. Frank;Scott E. Woodman;David S. Park;Michael P. Lisanti.
Arteriosclerosis, Thrombosis, and Vascular Biology (2003)

423 Citations

Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo.

William Schubert;Philippe G. Frank;Babak Razani;David S. Park.
Journal of Biological Chemistry (2001)

372 Citations

Apolipoprotein A-I: structure–function relationships

Philippe G. Frank;Yves L. Marcel.
Journal of Lipid Research (2000)

350 Citations

Caveolin-1 expression negatively regulates cell cycle progression by inducing G(0)/G(1) arrest via a p53/p21(WAF1/Cip1)-dependent mechanism.

Ferruccio Galbiati;Daniela Volonte;Jun Liu;Franco Capozza.
Molecular Biology of the Cell (2001)

340 Citations

Role of cholesterol in the development and progression of breast cancer

Gemma Llaverias;Christiane Danilo;Isabelle Mercier;Kristin Daumer.
American Journal of Pathology (2011)

290 Citations

Loss of stromal caveolin-1 leads to oxidative stress, mimics hypoxia and drives inflammation in the tumor microenvironment, conferring the "reverse Warburg effect": a transcriptional informatics analysis with validation

Stephanos Pavlides;Aristotelis Tsirigos;Iset Vera;Neal Flomenberg.
Cell Cycle (2010)

286 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Philippe G. Frank

Michael P. Lisanti

Michael P. Lisanti

University of Salford

Publications: 192

Federica Sotgia

Federica Sotgia

University of Salford

Publications: 129

Richard G. Pestell

Richard G. Pestell

The Wistar Institute

Publications: 62

Robert G. Parton

Robert G. Parton

University of Queensland

Publications: 48

Anthony Howell

Anthony Howell

University of Manchester

Publications: 46

Hemal H. Patel

Hemal H. Patel

University of California, San Diego

Publications: 41

Richard D. Minshall

Richard D. Minshall

University of Illinois at Chicago

Publications: 35

William C. Sessa

William C. Sessa

Yale University

Publications: 32

Philipp E. Scherer

Philipp E. Scherer

The University of Texas Southwestern Medical Center

Publications: 32

Asrar B. Malik

Asrar B. Malik

University of Illinois at Chicago

Publications: 24

Michael R. Freeman

Michael R. Freeman

Cedars-Sinai Medical Center

Publications: 24

David M. Roth

David M. Roth

GlaxoSmithKline (United Kingdom)

Publications: 23

Herbert B. Tanowitz

Herbert B. Tanowitz

Albert Einstein College of Medicine

Publications: 21

Isabelle Dugail

Isabelle Dugail

Grenoble Alpes University

Publications: 20

Pierre Sonveaux

Pierre Sonveaux

Université Catholique de Louvain

Publications: 20

Paola Chiarugi

Paola Chiarugi

University of Florence

Publications: 19

Trending Scientists

Aaron Thean

Aaron Thean

National University of Singapore

Mostafa Hajiaghaei-Keshteli

Mostafa Hajiaghaei-Keshteli

Monterrey Institute of Technology and Higher Education

Wen-Fu Fu

Wen-Fu Fu

Chinese Academy of Sciences

Yun Hang Hu

Yun Hang Hu

Michigan Technological University

Colin A. Fyfe

Colin A. Fyfe

University of British Columbia

Roger J. Daly

Roger J. Daly

Monash University

John B. Gaughan

John B. Gaughan

University of Queensland

Yisang Yoon

Yisang Yoon

Augusta University

Peter Sutovsky

Peter Sutovsky

University of Missouri

David J. Gower

David J. Gower

Natural History Museum

Hermann Katinger

Hermann Katinger

University of Natural Resources and Life Sciences

Chien-Fu Hung

Chien-Fu Hung

Johns Hopkins University

Mariano Esteban

Mariano Esteban

Spanish National Research Council

David F. Dinges

David F. Dinges

University of Pennsylvania

Frank Z. Stanczyk

Frank Z. Stanczyk

University of Southern California

Richard A. Rudick

Richard A. Rudick

Biogen (United States)

Something went wrong. Please try again later.